Skip to main content

Advertisement

SpringerLink
Log in

Albumin: a comprehensive review and practical guideline for clinical use

  • Research
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Nowadays, it is largely accepted that albumin should not be used in hypoalbuminemia or for nutritional purpose. The most discussed indication of albumin at present is the resuscitation in shock states, especially distributive shocks such as septic shock. The main evidence-based indication is also liver disease. In this review, we provided updated evidence-based instruction for definite and potential indications of albumin administration in clinical practice, with appropriate dosing and duration.

Methods

Data collection was carried out until November 2023 by search of electronic databases including PubMed, Google Scholar, Scopus, and Web of Science. GRADE system has been used to determine the quality of evidence and strength of recommendations for each albumin indication.

Results

A total of 165 relevant studies were included in this review. Fluid replacement in plasmapheresis and liver diseases, including hepatorenal syndrome, spontaneous bacterial peritonitis, and large-volume paracentesis, have a moderate to high quality of evidence and a strong recommendation for administering albumin. Moreover, albumin is used as a second-line and adjunctive to crystalloids for fluid resuscitation in hypovolemic shock, sepsis and septic shock, severe burns, toxic epidermal necrolysis, intradialytic hypotension, ovarian hyperstimulation syndrome, major surgery, non-traumatic brain injury, extracorporeal membrane oxygenation, acute respiratory distress syndrome, and severe and refractory edema with hypoalbuminemia has a low to moderate quality of evidence and weak recommendation to use. Also, in modest volume paracentesis, severe hyponatremia in cirrhosis has a low to moderate quality of evidence and a weak recommendation.

Conclusion

Albumin administration is most indicated in management of cirrhosis complications. Fluid resuscitation or treatment of severe and refractory edema, especially in patients with hypoalbuminemia and not responding to other treatments, is another rational use for albumin. Implementation of evidence-based guidelines in hospitals can be an effective measure to reduce inappropriate uses of albumin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Fanali G, Di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P (2012) Human serum albumin: from bench to bedside. Mol Aspects Med 33(3):209–290

    Article  CAS  PubMed  Google Scholar 

  2. Rothschild MA, Oratz M, Schreiber SS (1988) Serum albumin. Hepatology (Baltimore, MD) 8(2):385–401

    Article  CAS  PubMed  Google Scholar 

  3. Levitt DG, Levitt MD (2016) Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med 9:229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Caraceni P, Tufoni M, Bonavita ME (2013) Clinical use of albumin. Blood Transfus 11(Suppl 4):s18

    PubMed  PubMed Central  Google Scholar 

  5. Moman RN, Gupta N, Varacallo M (2017) Physiology, albumin. In: StatPearls. StatPearls Publishing, Treasure Island (FL). Accessed 26 Dec 2022

  6. Evans T (2002) Review article: albumin as drug-biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 16:6–11

    Article  CAS  PubMed  Google Scholar 

  7. Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, Bernardi M (2013) Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med 24(8):721–728

    Article  CAS  PubMed  Google Scholar 

  8. Yasumura S, Makino S, Matsumoto M, Kono T, Kino S, Tanaka A, Wakisaka A, Yonemura Y, Matsushita T (2017) Evidence-based guidelines for the use of albumin products Japan Society of Transfusion Medicine and Cell Therapy. Jpn J Transfus Cell Ther 63(5):641–663

    Article  Google Scholar 

  9. Zazzeron L, Gattinoni L, Caironi P (2016) Role of albumin, starches and gelatins versus crystalloids in volume resuscitation of critically ill patients. Curr Opin Crit Care 22(5):428–436

    Article  PubMed  Google Scholar 

  10. Adamik K-N, Yozova ID (2021) Colloids Yes or No?-a “Gretchen Question” Answered. Front Vet Sci 8:624049

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kazemi Y, Hadavand N, Hayatshahi A, Torkamandi H, Gholami K, Hadjibabaie M, Jahangard-Rafsanjani Z, Javadi MR (2013) Albumin utilization in a teaching hospital in Tehran: time to revise the prescribing strategies. J Pharm Care 1(4):127–132

    Google Scholar 

  12. Hajhossein TA, Jahangard RZ, Ziaie S, Fahimi F (2012) Evaluation of the pattern of human albumin utilization at a university affiliated hospital 15(2):85–87

    Google Scholar 

  13. Namazi S, Karimzadeh I (2011) Drug utilization evaluation of unfractionated heparin in a cardiac care unit in Iran. J Pharm Res 4(5):1470–1472

    Google Scholar 

  14. Aramwit P, Kasettratat N (2004) Evaluation of serum albumin utilization in inpatient at a private hospital in Bangkok. Yakugaku Zasshi 124(9):631–634

    Article  CAS  PubMed  Google Scholar 

  15. Vargas E, De Miguel V, Portolés A, Avendaño C, Ambit M, Torralba A, Moreno A (1997) Use of albumin in two Spanish university hospitals. Eur J Clin Pharmacol 52:465–470

    Article  CAS  PubMed  Google Scholar 

  16. Somers A, Bauters T, Robays H, Bogaert M, Colardyn F (2002) Evaluation of human albumin use in a university hospital in Belgium. Pharm World Sci 24:111–116

    Article  CAS  PubMed  Google Scholar 

  17. Tanzi M, Gardner M, Megellas M, Lucio S, Restino M (2003) Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm 60(13):1330–1335

    Article  CAS  PubMed  Google Scholar 

  18. Khamas SS, Mirbagheri I, Moghadam AD, Jafari A, Ashouri A (2021) Evaluation of albumin utilization in a major teaching hospital in Iran before and after guideline implementation. J Pharm Care 9(2):67–73

    Google Scholar 

  19. Zolfagharian F, Ghazanfari S, Elyasi S, Iraji P, Saberi MR, Vahdati-Mashhadian N, Mohammadpour AH (2017) Drug utilization evaluation of albumin in a teaching hospital of Mashhad, Iran: an interventional pre–post design study. Int J Clin Pharm 39(4):704–711

    Article  PubMed  Google Scholar 

  20. Taylor C, Yang L, Finfer S, Machado FR, YouZhong A, Billot L, Bloos F, Bozza F, Cavalcanti AB, Correa M (2021) An international comparison of the cost of fluid resuscitation therapies. Aust Crit Care 34(1):23–32

    Article  PubMed  Google Scholar 

  21. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, Schünemann HJ (2008) Going from evidence to recommendations. Bmj 336(7652):1049–1051

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gruartmoner G, Mesquida J, Ince C (2015) Fluid therapy and the hypovolemic microcirculation. Curr Opin Crit Care 21(4):276–284

    Article  CAS  PubMed  Google Scholar 

  23. Asim M, Alkadi MM, Asim H, Ghaffar A (2019) Dehydration and volume depletion: how to handle the misconceptions. World J Nephrol 8(1):23

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kreimeier U (2000) Pathophysiology of fluid imbalance. Crit Care 4(2):1–5

    Google Scholar 

  25. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD, Preiser JC, Outin H, Troché G, Charpentier C (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310(17):1809–1817

    Article  CAS  PubMed  Google Scholar 

  26. Investigators SS (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350(22):2247–2256

    Article  Google Scholar 

  27. Bellomo R, Morimatsu H, French C, Cole L, Story D, Uchino S, Naka T, Investigators SS (2006) The effects of saline or albumin resuscitation on acid-base status and serum electrolytes. Crit Care Med 34(12):2891–2897

    Article  CAS  PubMed  Google Scholar 

  28. au SSIsgoacac, (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37:86–96

    Article  Google Scholar 

  29. Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316(7136):961–964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Vincent J-L, De Backer D (2013) Circulatory shock. N Engl J Med 369(18):1726–1734

    Article  CAS  PubMed  Google Scholar 

  31. Taghavi S, Askari R (2022) Hypovolemic shock. In: StatPearls. StatPearls Publishing, Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK513297/. Accessed 5 June 2023

  32. Investigators SS (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357(9):874–884

    Article  Google Scholar 

  33. Wilkes MM, Navickis RJ (2001) Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med 135(3):149–164

    Article  CAS  PubMed  Google Scholar 

  34. Roberts I, Blackhall K, Alderson P, Bunn F, Schierhout G (2011) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 11:1–38

    Google Scholar 

  35. Monnet X, Malbrain ML, Pinsky MR (2023) The prediction of fluid responsiveness. Intensive Care Med 49(1):83–86

    Article  PubMed  Google Scholar 

  36. Mandel J, Palevsky PM (2023) Treatment of severe hypovolemia or hypovolemic shock in adults. UpToDate. Accessed 04 Dec 2023

  37. Holtz LR, Tarr PI, Kaplan SL (20203) Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment. UpToDate. Accessed 06 Feb 2023

  38. Lewis SR, Pritchard MW, Evans DJ, Butler AR, Alderson P, Smith AF, Roberts I (2018) Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 8:1–187

    Google Scholar 

  39. Fortin PM, Bassett K, Musini VM (2010) Human albumin for intradialytic hypotension in haemodialysis patients. Cochrane Database Syst Rev 11:1–14

    Google Scholar 

  40. Heming N, Elatrous S, Jaber S, Dumenil AS, Cousson J, Forceville X, Kimmoun A, Trouillet JL, Fichet J, Anguel N (2017) Haemodynamic response to crystalloids or colloids in shock: an exploratory subgroup analysis of a randomised controlled trial. BMJ Open 7(10):e016736

    Article  PubMed  PubMed Central  Google Scholar 

  41. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181–1247

    Article  PubMed  PubMed Central  Google Scholar 

  43. Martin GS, Bassett P (2019) Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: a systematic review and meta-analysis. J Crit Care 50:144–154

    Article  CAS  PubMed  Google Scholar 

  44. Park CHL, de Almeida JP, de Oliveira GQ, Rizk SI, Fukushima JT, Nakamura RE, Mourão MM, Galas FRBG, Abdala E, Freire MP (2019) Lactated ringer’s versus 4% albumin on lactated ringer’s in early sepsis therapy in cancer patients: a pilot single-center randomized trial. Crit Care Med 47(10):e798–e805

    Article  CAS  PubMed  Google Scholar 

  45. Kakaei F, Hashemzadeh S, Asheghvatan A, Zarrintan S, Asvadi T, Beheshtirouy S, Mohajer A (2017) Albumin as a resuscitative fluid in patients with severe sepsis: a randomized clinical trial. Adv Biosci Clin Med 5(4):8–16

    Article  Google Scholar 

  46. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370(15):1412–1421

    Article  CAS  PubMed  Google Scholar 

  47. Yu Y-T, Liu J, Hu B, Wang R-L, Yang X-H, Shang X-L, Wang G, Wang C-S, Li B-L, Gong Y (2021) Expert consensus on the use of human serum albumin in critically ill patients. Chin Med J 134(14):1639–1654

    Article  PubMed  Google Scholar 

  48. Tsai D, Lipman J, Roberts JA (2015) Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill. Curr Opin Crit Care 21(5):412–420

    Article  PubMed  Google Scholar 

  49. Burkhardt O, Kumar V, Katterwe D, Majcher-Peszynska J, Drewelow B, Derendorf H, Welte T (2007) Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. J Antimicrob Chemother 59(2):277–284

    Article  CAS  PubMed  Google Scholar 

  50. Barbot A, Venisse N, Rayeh F, Bouquet S, Debaene B, Mimoz O (2003) Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors. Intensive Care Med 29(9):1528–1534

    Article  CAS  PubMed  Google Scholar 

  51. Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J (2011) The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 50(2):99–110

    Article  CAS  PubMed  Google Scholar 

  52. Ramzy PI, Barret JP, Herndon DN (1999) Thermal injury. Crit Care Clin 15(2):333–352

    Article  CAS  PubMed  Google Scholar 

  53. Carter EA, Tompkins RG, Yarmush ML, Walker WA, Burke JF (1988) Redistribution of blood flow after thermal injury and hemorrhagic shock. J Appl Physiol 65(4):1782–1788

    Article  CAS  PubMed  Google Scholar 

  54. Haberal M, Abali AES, Karakayali H (2010) Fluid management in major burn injuries. Indian J Plast Surg 43(S 01):S29–S36

    Article  PubMed  PubMed Central  Google Scholar 

  55. Lawrence A, Faraklas I, Watkins H, Allen A, Cochran A, Morris S, Saffle J (2010) Colloid administration normalizes resuscitation ratio and ameliorates “fluid creep.” J Burn Care Res 31(1):40–47

    Article  PubMed  Google Scholar 

  56. Eljaiek R, Heylbroeck C, Dubois M-J (2017) Albumin administration for fluid resuscitation in burn patients: a systematic review and meta-analysis. Burns 43(1):17–24

    Article  PubMed  Google Scholar 

  57. Chen Y-F, Ma H, Perng C-K, Liao W-C, Shih Y-C, Lin C-H, Chen M-C, Hsiao F-Y, Wang T-H (2020) Albumin supplementation may have limited effects on prolonged hypoalbuminemia in major burn patients: an outcome and prognostic factor analysis. J Chin Med Assoc 83(2):206–210

    Article  CAS  PubMed  Google Scholar 

  58. Guilabert P, Usúa G, Martín N, Abarca L, Barret J, Colomina M (2016) Fluid resuscitation management in patients with burns: update. BJA Br J Anaesth 117(3):284–296

    Article  CAS  PubMed  Google Scholar 

  59. Chai J-k, Xia Z-f, Hu D-h, Tao B-j, Yi L, Meng Q-y, Chen J-h, Shen C-a, Peng Y-z, Liu H-q (2012) Consensus on use of albumin in burn patients. Med J Chin People’s Lib Army 37(10):755

    Google Scholar 

  60. Warden GD (1992) Burn shock resuscitation. World J Surg 16(1):16–23

    Article  CAS  PubMed  Google Scholar 

  61. Herb A Phelan M, MSCS, Eileen Bernal M (2022) Treatment of deep burns. UpToDate. Accessed 18 May 2022

  62. Downey A, Jackson C, Harun N, Cooper A (2012) Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol 66(6):995–1003

    Article  CAS  PubMed  Google Scholar 

  63. Shiga S, Cartotto R (2010) What are the fluid requirements in toxic epidermal necrolysis? J Burn Care Res 31(1):100–104

    Article  PubMed  Google Scholar 

  64. Nathasia TS (2020) Albumin, important therapy & when to use it in ten patients (adult & child): case report. J Dermatol Res Ther 6:3–7

    Article  Google Scholar 

  65. Schneider JA, Cohen PR (2017) Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Adv Ther 34(6):1235–1244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Sars B, van der Sande FM, Kooman JP (2020) Intradialytic hypotension: mechanisms and outcome. Blood Purif 49(1–2):158–167

    Article  PubMed  Google Scholar 

  67. Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A, Basile C, Ortiz A (2020) An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J 13(6):981–993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Emili S, Black NA, Paul RV, Rexing CJ, Ullian ME (1999) A protocol-based treatment for intradialytic hypotension in hospitalized hemodialysis patients. Am J Kidney Dis 33(6):1107–1114

    Article  CAS  PubMed  Google Scholar 

  69. Knoll GA, Grabowski JA, Dervin GF, O’Rourke K (2004) A randomized, controlled trial of albumin versus saline for the treatment of intradialytic hypotension. J Am Soc Nephrol 15(2):487–492

    Article  CAS  PubMed  Google Scholar 

  70. Luke B, Brown MB, Morbeck DE, Hudson SB, Coddington CC III, Stern JE (2010) Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril 94(4):1399–1404

    Article  CAS  PubMed  Google Scholar 

  71. Youssef MA, Al-Inany HG, Evers JL, Aboulghar M (2011) Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2:1–38

    Google Scholar 

  72. Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Papadimas I, Tarlatzis BC (2011) Intravenous albumin administration for the prevention of severe ovarian hyperstimulation syndrome: a systematic review and metaanalysis. Fertil Steril 95(1):188–196.e183

    Article  CAS  PubMed  Google Scholar 

  73. Jee BC, Suh CS, Kim YB, Kim SH, Choi YM, Kim JG, Moon SY (2010) Administration of intravenous albumin around the time of oocyte retrieval reduces pregnancy rate without preventing ovarian hyperstimulation syndrome: a systematic review and meta-analysis. Gynecol Obstet Invest 70(1):47–54

    Article  CAS  PubMed  Google Scholar 

  74. Pfeifer S, Butts S, Dumesic D, Fossum G, Gracia C, La Barbera A, Mersereau J, Odem R, Paulson R, Penzias A (2016) Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril 106(7):1634–1647

    Article  Google Scholar 

  75. Saremi A, Mahmodi Nia M, Zand Azad L, Nateghi MR, Sanaye Naderi M (2020) Comparing the mannitol and albumin in management of the severe ovarian hyperstimulation syndrome (OHSS), a randomized clinical trial, with cost-effectiveness analysis. Sarem J Med Res 5(2):86–94

    Article  Google Scholar 

  76. Lincoln SR, Opsahl MS, Blauer KL, Black SH, Schulman JD (2002) Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization. J Assist Reprod Genet 19(4):159–163

    Article  PubMed  PubMed Central  Google Scholar 

  77. Jenkins JM, Drakeley AJ, Mathur RS (2006) The management of ovarian hyperstimulation syndrome. Green-top guideline 5:1–11

    Google Scholar 

  78. Medicine PCotASfR, (2008) Ovarian hyperstimulation syndrome. Fertil Steril 90(5):S188–S193

    Article  Google Scholar 

  79. Shmorgun D, Claman P, Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Hughes EG, Min JK, Roberts J, Senikas V (2011) The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can 33(11):1156–1162

    Article  PubMed  Google Scholar 

  80. Reid S et al (2018) Ovarian hyperstimulation syndrome. South Australian Perinatal Practice Guideline 3:1–12

    Google Scholar 

  81. Newsome K, McKenny M, Elkbuli A (2021) Major and minor surgery: terms used for hundreds of years that have yet to be defined. Ann Med Surg 66:1–2

    Article  Google Scholar 

  82. Seretis C, Gill J, Malik A, Elhassan AM, Shariff U, Youssef H (2020) Low preoperative serum albumin levels are associated with impaired outcome after cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancies. J Clin Med Res 12(12):773

    Article  PubMed  PubMed Central  Google Scholar 

  83. Issangya CE, Msuya D, Chilonga K, Herman A, Shao E, Shirima F, Naman E, Mkumbi H, Pyuza J, Mtui E (2020) Perioperative serum albumin as a predictor of adverse outcomes in abdominal surgery: prospective cohort hospital based study in Northern Tanzania. BMC Surg 20(1):1–7

    Article  Google Scholar 

  84. Mahkovic-Hergouth K, Kompan L (2011) Is replacement of albumin in major abdominal surgery useful? J Clin Anesth 23(1):42–46

    Article  PubMed  Google Scholar 

  85. Heming N, Lamothe L, Jaber S, Trouillet JL, Martin C, Chevret S, Annane D (2018) Morbidity and mortality of crystalloids compared to colloids in critically ill surgical patients: a subgroup analysis of a randomized trial. Anesthesiology 129(6):1149–1158

    Article  PubMed  Google Scholar 

  86. Haynes G, Navickis R, Wilkes M (2003) Albumin administration–what is the evidence of clinical benefit? A systematic review of randomized controlled trials. Eur J Anaesthesiol 20(10):771–793

    Article  CAS  PubMed  Google Scholar 

  87. Dubois M-J, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, Brimioulle S, Appoloni O, Creteur J, Vincent J-L (2006) Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34(10):2536–2540

    Article  CAS  PubMed  Google Scholar 

  88. Sahmeddini M, Janatmakan F, Khosravi M, Ghaffaripour S, Eghbal M, Nickeghbalian S, Malek-Hosseini S (2014) Restricted crystalloid fluid therapy during orthotopic liver transplant surgery and its effect on respiratory and renal insufficiency in the early post-operative period: a randomized clinical trial. Int J Organ Transplant Med 5(3):113

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Kayambankadzanja RK, Schell CO, Wärnberg MG, Tamras T, Mollazadegan H, Holmberg M, Alvesson HM, Baker T (2022) Towards definitions of critical illness and critical care using concept analysis. BMJ Open 12(9):e060972

    Article  PubMed  PubMed Central  Google Scholar 

  90. Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim Jy, Choo SJ, Chung CH, Lee JW, Choi IC (2016) Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g/dl. Anesthesiology 124(5):1001–1011

    Article  CAS  PubMed  Google Scholar 

  91. Nadim MK, Forni LG, Bihorac A, Hobson C, Koyner JL, Shaw A, Arnaoutakis GJ, Ding X, Engelman DT, Gasparovic H (2018) Cardiac and vascular surgery–associated acute kidney injury: the 20th international consensus conference of the ADQI (acute disease quality initiative) group. J Am Heart Assoc 7(11):e008834

    Article  PubMed  PubMed Central  Google Scholar 

  92. Hanley C, Callum J, Karkouti K, Bartoszko J (2021) Albumin in adult cardiac surgery: a narrative review. Can J Anesth 68(8):1197–1213

    Article  CAS  PubMed  Google Scholar 

  93. Karas PL, Goh SL, Dhital K (2015) Is low serum albumin associated with postoperative complications in patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 21(6):777–786

    PubMed  Google Scholar 

  94. Lambert KG, Wakim JH, Lambert NE (2009) Preoperative fluid bolus and reduction of postoperative nausea and vomiting in patients undergoing laparoscopic gynecologic surgery. AANA J 77(2):110–114

    PubMed  Google Scholar 

  95. Hooper VD (2015) SAMBA consensus guidelines for the management of postoperative nausea and vomiting: an executive summary for perianesthesia nurses. J Perianesth Nurs 30(5):377–382

    Article  PubMed  Google Scholar 

  96. Miller TE, Myles PS (2019) Perioperative fluid therapy for major surgery. Anesthesiology 130(5):825–832

    Article  PubMed  Google Scholar 

  97. Thacker JK, Mountford WK, Ernst FR, Krukas MR, Mythen MMG (2016) Perioperative fluid utilization variability and association with outcomes. Ann Surg 263(3):502–510

    Article  PubMed  Google Scholar 

  98. Brandstrup B (2006) Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol 20(2):265–283

    Article  PubMed  Google Scholar 

  99. Kabon B, Sessler DI, Kurz A (2019) Effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity: a randomized trial. Anesthesiology 130(5):728–744

    Article  PubMed  Google Scholar 

  100. Joosten A, Delaporte A, Mortier J, Ickx B, Van Obbergh L, Vincent J-L, Cannesson M, Rinehart J, Van der Linden P (2019) Long-term impact of crystalloid versus colloid solutions on renal function and disability-free survival after major abdominal surgery. Anesthesiology 130(2):227–236

    Article  CAS  PubMed  Google Scholar 

  101. Heming N, Moine P, Coscas R, Annane D (2020) Perioperative fluid management for major elective surgery. J Br Surg 107(2):e56–e62

    Article  CAS  Google Scholar 

  102. Brien LD, Oermann MH, Molloy M, Tierney C (2020) Implementing a goal-directed therapy protocol for fluid resuscitation in the cardiovascular intensive care unit. AACN Adv Crit Care 31(4):364–370

    Article  PubMed  Google Scholar 

  103. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossettias G (2009) Recommendations for the use of albumin and immunoglobulins. Blood Transfus 7(3):216

    PubMed  PubMed Central  Google Scholar 

  104. Mahkovic Hergouth K, Kompan L (2007) Replacement of albumin after abdominal surgery. Crit Care 11(2):1–1

    Google Scholar 

  105. Yuan X-Y, Zhang C-H, He Y-L, Yuan Y-X, Cai S-R, Luo N-X, Zhan W-H, Cui J (2008) Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery?: a prospective randomized controlled trial. Am J Surg 196(5):751–755

    Article  CAS  PubMed  Google Scholar 

  106. Rabin J, Meyenburg T, Lowery AV, Rouse M, Gammie JS, Herr D (2017) Restricted albumin utilization is safe and cost effective in a cardiac surgery intensive care unit. Ann Thorac Surg 104(1):42–48

    Article  PubMed  Google Scholar 

  107. Mwaura L, Vuylsteke A (2019) Fueling the debate on albumin after cardiac surgery. J Cardiothorac Vasc Anesth 33(11):2928–2929

    Article  PubMed  Google Scholar 

  108. Matebele MP, Ramanan M, Thompson K, Cornmell G, Naidoo RV, Shekar K (2020) Albumin use after cardiac surgery. Crit Care Explor 2(7):1–7

    Article  Google Scholar 

  109. Sergent SR, Ashurst JV (2022) Plasmapheresis. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560566/. Accessed 10 July 2023

  110. Kohli R, Geneen LJ, Brunskill SJ, Doree C, Estcourt L, Chee SE, Al-Bader R, Sin WY, MacCallum P, Green L (2022) Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: a systematic scoping review of outcome measures used. J Clin Apheresis 37(5):438–448

    Article  PubMed  Google Scholar 

  111. McLeod BC (2012) Plasma and plasma derivatives in therapeutic plasmapheresis. Transfusion 52:38S-44S

    Article  CAS  PubMed  Google Scholar 

  112. Tabor E (1999) The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. Transfusion 39(11–12):1160–1168

    Article  CAS  PubMed  Google Scholar 

  113. Arslan Ö, Arat M, Göktürk S, AYYILDIZ E, İlhan O, (2003) Therapeutic plasma exchange and the clinical applications. Turk J Haematol 20(1):7–17

    PubMed  Google Scholar 

  114. Walker R (1993) Technical manual of the American association of blood banks, 11th edn. Am Assoc Blood Banks, Bethesda, USA

  115. Bauer PR, Ostermann M, Russell L, Robba C, David S, Ferreyro BL, Cid J, Castro P, Juffermans NP, Montini L (2022) Plasma exchange in the intensive care unit: a narrative review. Intensive Care Med 48(10):1382–1396

    Article  PubMed  PubMed Central  Google Scholar 

  116. Irani MS, Toushan M, Zhang L, Simpson PM, Karafin MS (2019) Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange. J Clin Apheresis 34(5):524–527

    Article  PubMed  Google Scholar 

  117. Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y (2019) Guidelines on the use of therapeutic apheresis in clinical practice–evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apheresis 34(3):171–354

    Article  PubMed  Google Scholar 

  118. Martin G (2016) Acute brain trauma. Ann R Coll Surg Engl 98(1):6–10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD (2006) The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke—II: neurologic outcome and efficacy analysis. Stroke 37(8):2107–2114

    Article  CAS  PubMed  Google Scholar 

  120. Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY (2016) ALIAS (Albumin in acute ischemic stroke) trials: analysis of the combined data from parts 1 and 2. Stroke 47(9):2355–2359

    Article  PubMed  PubMed Central  Google Scholar 

  121. Suarez JI, Shannon L, Zaidat OO, Suri MF, Singh G, Lynch G, Selman WR (2004) Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg 100(4):585–590

    Article  CAS  PubMed  Google Scholar 

  122. Kuwabara K, Fushimi K, Matsuda S, Ishikawa KB, Horiguchi H, Fujimori K (2013) Association of early post-procedure hemodynamic management with the outcomes of subarachnoid hemorrhage patients. J Neurol 260(3):820–831

    Article  PubMed  Google Scholar 

  123. Ibrahim GM, Macdonald RL (2013) The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. Neurocrit Care 19(2):140–149

    Article  CAS  PubMed  Google Scholar 

  124. Tone O, Ito U, Tomita H, Masaoka H, Tominaga B (1994) High colloid oncotic therapy for brain edema with cerebral hemorrhage. Acta Neurochir Suppl 60:568–570

    CAS  PubMed  Google Scholar 

  125. Huang Z, Dong W, Yan Y, Xiao Q, Man Y (2002) Effects of intravenous human albumin and furosemide on EEG recordings in patients with intracerebral hemorrhage. Clin Neurophysiol 113(3):454–458

    Article  CAS  PubMed  Google Scholar 

  126. Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, Billot L, Murray L, Vallance tS-TI, Australian t, New Zealand Intensive Care Society Clinical Trials Group S (2013) Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma 30(7):512–518

    Article  Google Scholar 

  127. Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA, Bernard GR, Burchiel KJ, Burnett DA, Cerra FB, Drew MJ (1995) A paradigm for consensus: the University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 155(4):373–379

    Article  PubMed  Google Scholar 

  128. Bessos H, Fraser R, Seghatchian J (2011) Scotblood 2010: Key presentations of the past, present, and future of transfusion medicine to mark Scottish national blood transfusion service (SNBTS) anniversaries. Transfus Apheres Sci 45(2):213–221

    Article  Google Scholar 

  129. Dijkink S, Meier K, Krijnen P, Yeh DD, Velmahos GC, Arbous MS, Salim A, Hoogendoorn JM, Schipper IB (2019) The malnutrition in polytrauma patients (MaPP) study: research protocol. Nutr Health 25(4):291–301

    Article  PubMed  PubMed Central  Google Scholar 

  130. Baran DA (2017) Extracorporeal membrane oxygenation (ECMO) and the critical cardiac patient. Curr Trans Rep 4:218–225

    Article  Google Scholar 

  131. Moret E, Jacob MW, Ranucci M, Schramko AA (2014) Albumin—beyond fluid replacement in cardiopulmonary bypass surgery: why, how, and when? Seminars in cardiothoracic and vascular anesthesiaed. SAGE Publications Sage CA, Los Angeles, CA, pp 252–259

    Google Scholar 

  132. Russell JA, Navickis RJ, Wilkes MM (2004) Albumin versus crystalloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth 18(4):429–437

    Article  CAS  PubMed  Google Scholar 

  133. Zimmermann AK, Weber N, Aebert H, Ziemer G, Wendel HP (2007) Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators. J Biomed Mater Res Part B Appl Biomater Official J Soc Biomateri Jpn Soc Biomat Aust Soc Biomat Korean Soc Biomat 80(2):433–439

    Article  Google Scholar 

  134. Roberts TR, Garren M, Handa H, Batchinsky AI (2020) Toward an artificial endothelium: development of blood-compatible surfaces for extracorporeal life support. J Trauma Acute Care Surg 89(2):S59

    Article  PubMed  PubMed Central  Google Scholar 

  135. Wengenmayer T, Schroth F, Biever PM, Duerschmied D, Benk C, Trummer G, Kaier K, Bode C, Staudacher DL (2018) Albumin fluid resuscitation in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy is associated with improved survival. Intensive Care Med 44(12):2312–2314

    Article  PubMed  Google Scholar 

  136. Gounden V, Vashisht R, Jialal I (2018) Hypoalbuminemia. In: StatPearls. StatPearls Publishing, Treasure Island (FL). https://europepmc.org/article/nbk/nbk526080. Accessed 26 Sep 2018

  137. O’Brien JG, Chennubhotla SA, Chennubhotal RV (2005) Treatment of edema. Am Fam Physician 71(11):2111–2117

    PubMed  Google Scholar 

  138. Anisman SD, Erickson SB, Morden NE (2019) How to prescribe loop diuretics in oedema. Bmj 364

  139. Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y (1987) Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 32(2):198–203

    Article  CAS  PubMed  Google Scholar 

  140. Lee TH, Kuo G, Chang C-H, Huang YT, Yen CL, Lee C-C, Fan PC, Chen J-J (2021) Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: an updated systematic review and meta-analysis. PLoS ONE 16(12):e0260312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Force ADT, Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, Fan E, Camporota L, Slutsky A (2012) Acute respiratory distress syndrome. Jama 307(23):2526–2533

    Google Scholar 

  142. Mendes RdS, Pelosi P, Schultz MJ, Rocco PR, Silva PL (2020) Fluids in ARDS: more pros than cons. Intensive Care Med Exp 8(1):1–11

    Article  Google Scholar 

  143. Vaglio S, Calizzani G, Lanzoni M, Candura F, Profili S, Catalano L, Cannata L, Liumbruno GM, Grazzini G (2013) The demand for human albumin in Italy. Blood Transfus 11(Suppl 4):s26

    PubMed  PubMed Central  Google Scholar 

  144. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR (2005) A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 33(8):1681–1687

    Article  CAS  PubMed  Google Scholar 

  145. Martin GS, Mangialardi RJ, Wheeler AP, Dupont WD, Morris JA, Bernard GR (2002) Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 30(10):2175–2182

    Article  CAS  PubMed  Google Scholar 

  146. Cordemans C, Van Regenmortel N, Schoonheydt K, Dits H, Martin G, Huber W, Malbrain ML (2012) Aiming for a negative fluid balance in patients with acute lung injury and increased intra-abdominal pressure: a pilot study looking at the effects of PAL-treatment. Ann Intensive Care 2(1):1–11

    Article  Google Scholar 

  147. Oczkowski SJ, Mazzetti I (2014) Colloids to improve diuresis in critically ill patients: a systematic review. J Intensive Care 2(1):1–6

    Article  Google Scholar 

  148. Uhlig C, Silva PL, Deckert S, Schmitt J, de Abreu MG (2014) Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 18(1):1–8

    Article  Google Scholar 

  149. Griffiths MJ, McAuley DF, Perkins GD, Barrett N, Blackwood B, Boyle A, Chee N, Connolly B, Dark P, Finney S (2019) Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res 6(1):e000420

    Article  PubMed  PubMed Central  Google Scholar 

  150. Saguil A, Fargo MV (2020) Acute respiratory distress syndrome: diagnosis and management. Am Fam Physician 101(4):730–738

    PubMed  Google Scholar 

  151. Brater DC, Ellison DH, Emmett M (2023) Causes and treatment of refractory edema in adults. UpToDate. Accessed 30 Aug 2023

  152. Siqueira F, Kelly T, Saab S (2009) Refractory ascites: pathogenesis, clinical impact, and management. Gastroenterol Hepatol 5(9):647

    Google Scholar 

  153. Wang C-s, Greenbaum LA (2019) Nephrotic syndrome. Pediatr Clin 66(1):73–85

    CAS  Google Scholar 

  154. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G (1999) Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 30(4):639–645

    Article  CAS  PubMed  Google Scholar 

  155. Fliser D, Zurbrüggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E (1999) Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55(2):629–634

    Article  CAS  PubMed  Google Scholar 

  156. Chalasani N, Gorski JC, Horlander JC, Craven R, Hoen H, Maya J, Brater DC (2001) Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12(5):1010–1016

    Article  CAS  PubMed  Google Scholar 

  157. Kodner C (2016) Diagnosis and management of nephrotic syndrome in adults. Am Fam Physician 93(6):479–485

    PubMed  Google Scholar 

  158. Duffy M, Jain S, Harrell N, Kothari N, Reddi AS (2015) Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies. Cells 4(4):622–630

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Arroyo V, Fernandez J (2016) Pathophysiological basis of albumin use in cirrhosis. Ann Hepatol 10(S1):6–14

    Google Scholar 

  160. Peralta R et al (2020) Hypoalbuminemia: background, pathophysiology, etiology. Medscape. https://emedicine.medscape.com/article/166724-overview. Accessed 11 Sep 2020

  161. de Mattos ÂZ, Simonetto DA, Terra C, Farias AQ, Lisboa P, Bittencourt THSP, Toazza MR, de Mattos AA (2022) Albumin administration in patients with cirrhosis: current role and novel perspectives. World J Gastroenterol 28(33):4773–4786

    Article  PubMed  PubMed Central  Google Scholar 

  162. Tufoni M, Zaccherini G, Caraceni P, Bernardi M (2020) Albumin: indications in chronic liver disease. United Eur Gastroenterol J 8(5):528–535

    Article  Google Scholar 

  163. Angeli P, Albino G, Carraro P, Pria M, Merkel C, Caregaro L, De Bei E, Bortoluzzi A, Plebani M, Gatta A (1996) Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology 23(2):264–273

    Article  CAS  PubMed  Google Scholar 

  164. Shasthry SM, Kumar M, Khumuckham JS, Sarin SK (2017) Changes in cardiac output and incidence of volume overload in cirrhotics receiving 20% albumin infusion. Liver Int 37(8):1167–1176

    Article  CAS  PubMed  Google Scholar 

  165. Jagdish RK, Maras JS, Sarin SK (2021) Albumin in advanced liver diseases: the good and bad of a drug! Hepatology 74(5):2848–2862

    Article  CAS  PubMed  Google Scholar 

  166. Subedi A, Kumar VCS, Subedi AS, Sapkota B (2021) A review of hepatorenal syndrome. Cureus 13(7):1–9

    Google Scholar 

  167. Diaconescu D, Pantea Stoian A, Socea LI, Stanescu AMA, Iancu MA, Socea B, Pituru S, Bratu O, Diaconu C (2018) Hepatorenal syndrome: a review. Arch Balk Med Union 53(2):239–245

    Article  CAS  Google Scholar 

  168. Simonetto DA, Gines P, Kamath PS (2020) Hepatorenal syndrome: pathophysiology, diagnosis, and management. Bmj 370:1–15

    Google Scholar 

  169. Facciorusso A, Chandar AK, Murad MH, Prokop LJ, Muscatiello N, Kamath PS, Singh S (2017) Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2(2):94–102

    Article  PubMed  Google Scholar 

  170. Biggins SW, Angeli P, Garcia-Tsao G, Ginès P, Ling SC, Nadim MK, Wong F, Kim WR (2021) Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases. Hepatology 74(2):1014–1048

    Article  PubMed  Google Scholar 

  171. Bai Z et al (2023) Use of albumin infusion for cirrhosis-related complications: an international position statement. JHEP Rep 5(8):1–15

    Google Scholar 

  172. Nadim MK, Durand F, Kellum JA, Levitsky J, O’Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P (2016) Management of the critically ill patient with cirrhosis: a multidisciplinary perspective. J Hepatol 64(3):717–735

    Article  PubMed  Google Scholar 

  173. Such J, Runyon BA (1998) Spontaneous bacterial peritonitis. Clin Infect Dis 27(4):669–674

    Article  CAS  PubMed  Google Scholar 

  174. Duah A, Nkrumah KN (2019) Spontaneous bacterial peritonitis among adult patients with ascites attending Korle-Bu Teaching Hospital. Ghana Med J 53(1):37–43

    Article  PubMed  PubMed Central  Google Scholar 

  175. Batool S, Waheed MD, Vuthaluru K, Jaffar T, Garlapati SKP, Bseiso O, Nousherwani MD, Saleem F (2022) Efficacy of intravenous albumin for spontaneous bacterial peritonitis infection among patients with cirrhosis: a meta-analysis of randomized control trials. Cureus 14(12):1–8

    Google Scholar 

  176. Salerno F, Navickis RJ, Wilkes MM (2013) Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol 11(2):123-130.e121

    Article  CAS  PubMed  Google Scholar 

  177. Lindsay AJ, Burton J, Ray CE Jr (2014). In: Seminars in interventional radiology (ed) Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist. Thieme Medical Publishers, pp 276–278

    Google Scholar 

  178. Alsebaey A, Rewisha E, Waked I (2020) Paracentesis-induced circulatory dysfunction: are there albumin alternatives? Egypt Liver J 10(1):1–6

    Google Scholar 

  179. Runyon BA, Committee APG (2013) Management of adult patients with ascites due to cirrhosis: update 2012. Hepatology 57(4):1651–1653

    Article  PubMed  Google Scholar 

  180. Liver EAfTSot, (2018) EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol 69(2):406–460

    Article  Google Scholar 

  181. John S, Thuluvath PJ (2015) Hyponatremia in cirrhosis: pathophysiology and management. World J Gastroenterol: WJG 21(11):3197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  182. China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, Portal AJ, Becares Salles N, Gilroy DW, O’Brien A (2021) A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med 384(9):808–817

    Article  CAS  PubMed  Google Scholar 

  183. McCormick P, Mistry P, Kaye G, Burroughs A, McIntyre N (1990) Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites. Gut 31(2):204–207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  184. Jalan R, Mookerjee R, Cheshire L, Williams R, Davies N (2007) [232] Albumin infusion for severe hyponatremia in patients with refractory ascites: a randomized clinical trial. J Hepatol 46:S95

    Article  Google Scholar 

  185. Bajaj JS, Tandon P, O’Leary JG, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai JC, Fallon M (2018) The impact of albumin use on resolution of hyponatremia in hospitalized patients with cirrhosis. Official J Am Coll Gastroenterol ACG 113(9):1339

    Article  CAS  Google Scholar 

  186. Fernández J, Clària J, Amorós A, Aguilar F, Castro M, Casulleras M, Acevedo J, Duran-Güell M, Nuñez L, Costa M (2019) Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis. Gastroenterology 157(1):149–162

    Article  PubMed  Google Scholar 

  187. Caraceni P, Tufoni M, Zaccherini G, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A (2021) On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites. J Hepatol 74(2):340–349

    Article  CAS  PubMed  Google Scholar 

  188. Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G (2018) Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. The Lancet 391(10138):2417–2429

    Article  CAS  Google Scholar 

  189. Romanelli RG, La Villa G, Barletta G, Vizzutti F, Lanini F, Arena U, Boddi V, Tarquini R, Pantaleo P, Gentilini P (2006) Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. World J Gastroenterol: WJG 12(9):1403

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  190. Di Pascoli M, Fasolato S, Piano S, Bolognesi M, Angeli P (2019) Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites. Liver Int 39(1):98–105

    Article  PubMed  Google Scholar 

  191. Sandi BB, Leão GS, de Mattos AA, de Mattos ÂZ (2021) Long-term albumin administration in patients with cirrhosis and ascites: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 36(3):609–617

    Article  CAS  PubMed  Google Scholar 

  192. Ashour AA, Atta MA, Sadek KW, Obaid KR, Ashour MA, Ashour A, Danjuma MI, Doi SA, ElZouki A-N (2021) Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update. Eur J Gastroenterol Hepatol 33(4):479–486

    Article  PubMed  Google Scholar 

  193. Trebicka J (2022) Role of albumin in the treatment of decompensated liver cirrhosis. Curr Opin Gastroenterol 38(3):200–205

    Article  CAS  PubMed  Google Scholar 

  194. Thabut D, Bouzbib C, Meunier L, Haas M, Weiss N, Louvet A, Imbert-Bismut F, Mochel F, Nadjar Y, Santiago A (2023) Diagnosis and management of hepatic encephalopathy: the French recommendations. Liver Int 43(4):750–762

    Article  PubMed  Google Scholar 

  195. Jalan R, Kapoor D (2004) Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci 106(5):467–474

    Article  CAS  Google Scholar 

  196. Simón-Talero M, García-Martínez R, Torrens M, Augustin S, Gómez S, Pereira G, Guevara M, Ginés P, Soriano G, Román E (2013) Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol 59(6):1184–1192

    Article  PubMed  Google Scholar 

  197. Sharma BC, Singh J, Srivastava S, Sangam A, Mantri AK, Trehanpati N, Sarin SK (2017) Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. J Gastroenterol Hepatol 32(6):1234–1239

    Article  CAS  PubMed  Google Scholar 

  198. Bombassaro IZ, Tovo CV, de Mattos ÂZ, Ahlert M, Chiesa T, de Mattos AA (2021) Albumin in the management of hepatic encephalopathy: a systematic review and meta-analysis. Ann Hepatol 26:100541

    Article  PubMed  Google Scholar 

  199. Teh KB, Loo JH, Tam YC, Wong YJ (2021) Efficacy and safety of albumin infusion for overt hepatic encephalopathy: a systematic review and meta-analysis. Dig Liver Dis 53(7):817–823

    Article  CAS  PubMed  Google Scholar 

  200. Wong YJ, Loo JH (2023) Albumin therapy for hepatic encephalopathy: current evidence and controversies. Metab Brain Dis 38(5):1759–1763

    Article  CAS  PubMed  Google Scholar 

  201. Pompili E, Zaccherini G, Baldassarre M, Iannone G, Caraceni P (2023) Albumin administration in internal medicine: a journey between effectiveness and futility. Eur J Intern Med 117:28–37

    Article  CAS  PubMed  Google Scholar 

  202. Cooper BA, Penne EL, Bartlett LH, Pollock CA (2004) Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 43(1):61–66

    Article  PubMed  Google Scholar 

  203. Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: pathogenesis and clinical significance. J Parenter Enter Nutr 43(2):181–193

    Article  CAS  Google Scholar 

  204. Mobarhan S (1988) The role of albumin in nutritional support. J Am Coll Nutr 7(6):445–452

    Article  CAS  PubMed  Google Scholar 

  205. Ashworth A (2001) Treatment of severe malnutrition. J Pediatr Gastroenterol Nutr 32(5):516–518

    CAS  PubMed  Google Scholar 

  206. Wong Y, Shuttleworth G, Wood B (1972) Effect of albumin administration on phototherapy for neonatal jaundice. Arch Dis Child 47(252):241–245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  207. Shahian M, Moslehi MA (2010) Effect of albumin administration prior to exchange transfusion in term neonates with hyperbilirubinemia—a randomized controlled trial. Indian Pediatr 47(3):241–244

    Article  PubMed  Google Scholar 

  208. Dash N, Kumar P, Sundaram V, Attri SV (2015) Pre-exchange albumin administration in neonates with hyperbilirubinemia: a randomized controlled trial. Indian Pediatr 52(9):763–767

    Article  PubMed  Google Scholar 

  209. Roy-Chowdhury N, Roy-Chowdhury J, Lindor KD, Grover S (2023) Crigler-Najjar syndrome. UpToDate. Accessed 14 Sep 2023

  210. Maiwall R, Kumar A, Pasupuleti SSR, Hidam AK, Tevethia H, Kumar G, Sahney A, Mitra LG, Sarin SK (2022) A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. J Hepatol 77(3):670–682

    Article  CAS  PubMed  Google Scholar 

  211. Li Z, Ling Y, Yuan X, Liu X, Huang W, Chen Q, Wang J, Chen Y, Xu M, Wu B (2022) Impact of albumin infusion on prognosis of intensive care unit patients with congestive heart failure-hypoalbuminemia overlap: a retrospective cohort study. J Thorac Dis 14(6):2235

    Article  PubMed  PubMed Central  Google Scholar 

  212. Wang L, Zhao Y-T (2022) Albumin infusion in hospitalized patients with acute heart failure: a retrospective cohort study. BMC Cardiovasc Disord 22(1):1–8

    Article  Google Scholar 

  213. Wilcox CS, Testani JM, Pitt B (2020) Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure. Hypertension 76(4):1045–1054

    Article  CAS  PubMed  Google Scholar 

  214. Phillips M, Thomas D, Bolduc C, Arreymbi T, Rubal B, Slim A (2014) Does albumin infusion improve loop diuretic efficacy and reduce third spacing in patients treated for acute heart failure? case series and literature review. Austin J Cardiovasc Dis Atherosclerosis 1(1):2

    Google Scholar 

  215. Talukder A, Siraj MM, Khondokar MN, Habib SA, Salim MA, Rahman MW, Banerjee SK, Ahsan SA, Hoque MH, Rahman F (2019) Outcome of albumin infusion in heart failure patients. Univ Heart J 15(2):47–53

    Article  Google Scholar 

  216. Guevara M, Terra C, Nazar A, Solà E, Fernández J, Pavesi M, Arroyo V, Ginès P (2012) Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol 57(4):759–765

    Article  CAS  PubMed  Google Scholar 

  217. Thévenot T, Bureau C, Oberti F, Anty R, Louvet A, Plessier A, Rudler M, Heurgué-Berlot A, Rosa I, Talbodec N (2015) Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J Hepatol 62(4):822–830

    Article  PubMed  Google Scholar 

  218. Fernández J, Angeli P, Trebicka J, Merli M, Gustot T, Alessandria C, Aagaard NK, De Gottardi A, Welzel TM, Gerbes A (2020) Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol 18(4):963-973.e914

    Article  PubMed  Google Scholar 

  219. Mattos ÂZ, Leão GS, Mattos AA (2020) Albumin for infections other than spontaneous bacterial peritonitis: still not an answer. Clin Gastroenterol Hepatol 18(5):1247–1248

    Article  PubMed  Google Scholar 

  220. Leao GS, John Neto G, Jotz RdF, Mattos AAd, Mattos ÂZd (2019) Albumin for cirrhotic patients with extraperitoneal infections: a meta-analysis. J Gastroenterol Hepatol 34(12):2071–2076

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Author notes

  1. Batool Zarei and Sepideh Elyasi contributed equally.

Authors and Affiliations

  1. Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, P.O. Box, Mashhad, 91775-1365, Iran

    Farshad Abedi, Batool Zarei & Sepideh Elyasi

Authors
  1. Farshad Abedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Batool Zarei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sepideh Elyasi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Batool Zarei and Farshad Abedi drafted the article. 

Corresponding authors

Correspondence to Batool Zarei or Sepideh Elyasi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abedi, F., Zarei, B. & Elyasi, S. Albumin: a comprehensive review and practical guideline for clinical use. Eur J Clin Pharmacol (2024). https://doi.org/10.1007/s00228-024-03664-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00228-024-03664-y

Keywords

Search

Navigation